Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Overcoming therapeutic resistance in glioblastoma: the way forward.

Osuka S, Van Meir EG.

J Clin Invest. 2017 Feb 1;127(2):415-426. doi: 10.1172/JCI89587. Epub 2017 Feb 1. Review.

PMID:
28145904
2.

Targeting glioma stem cells enhances anti-tumor effect of boron neutron capture therapy.

Sun T, Li Y, Huang Y, Zhang Z, Yang W, Du Z, Zhou Y.

Oncotarget. 2016 Jul 12;7(28):43095-43108. doi: 10.18632/oncotarget.9355.

3.

MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.

Yang W, Yu H, Shen Y, Liu Y, Yang Z, Sun T.

Oncotarget. 2016 Jul 5;7(27):41505-41526. doi: 10.18632/oncotarget.9214.

4.

Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets.

Codrici E, Enciu AM, Popescu ID, Mihai S, Tanase C.

Stem Cells Int. 2016;2016:5728438. doi: 10.1155/2016/5728438. Epub 2016 Feb 10. Review.

5.
6.

Differentiation of Glioma Stem Cells and Progenitor Cells into Local Host Cell-Like Cells: A Study Based on Choroidcarcinoma Differentiation of Choroid Plexus of GFP Transgenic Nude Mouse.

Wang Z, Fei X, Dai X, Chen H, Tian H, Wang A, Dong J, Huang Q.

Cancer Biother Radiopharm. 2015 Jun;30(5):225-32. doi: 10.1089/cbr.2014.1722.

7.

Astrocytoma-associated antigens - IL13Rα2, Fra-1, and EphA2 as potential markers to monitor the status of tumour-derived cell cultures in vitro.

Witusik-Perkowska M, Zakrzewska M, Szybka M, Papierz W, Jaskolski DJ, Liberski PP, Sikorska B.

Cancer Cell Int. 2014 Aug 22;14:82. doi: 10.1186/s12935-014-0082-z. eCollection 2014 Aug 22.

8.

Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.

Kristoffersen K, Nedergaard MK, Villingshøj M, Borup R, Broholm H, Kjær A, Poulsen HS, Stockhausen MT.

Cancer Biol Ther. 2014 Jul;15(7):862-77. doi: 10.4161/cbt.28876. Epub 2014 Apr 22.

9.

Differential Nrf2 expression between glioma stem cells and non-stem-like cells in glioblastoma.

Zhu J, Wang H, Ji X, Zhu L, Sun Q, Cong Z, Zhou Y, Liu H, Zhou M.

Oncol Lett. 2014 Mar;7(3):693-698. Epub 2013 Dec 16.

10.

Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells.

Qiu ZK, Shen D, Chen YS, Yang QY, Guo CC, Feng BH, Chen ZP.

Chin J Cancer. 2014 Feb;33(2):115-22. doi: 10.5732/cjc.012.10236. Epub 2013 Aug 6.

11.

Boron neutron capture therapy induces cell cycle arrest and cell apoptosis of glioma stem/progenitor cells in vitro.

Sun T, Zhang Z, Li B, Chen G, Xie X, Wei Y, Wu J, Zhou Y, Du Z.

Radiat Oncol. 2013 Aug 6;8(1):195. doi: 10.1186/1748-717X-8-195.

12.

The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.

Cox JL, Wilder PJ, Gilmore JM, Wuebben EL, Washburn MP, Rizzino A.

PLoS One. 2013 May 7;8(5):e62857. doi: 10.1371/journal.pone.0062857. Print 2013.

13.

NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro.

Wang WJ, Long LM, Yang N, Zhang QQ, Ji WJ, Zhao JH, Qin ZH, Wang Z, Chen G, Liang ZQ.

Acta Pharmacol Sin. 2013 May;34(5):681-90. doi: 10.1038/aps.2013.22. Epub 2013 Apr 22.

14.

Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.

Baronchelli S, Bentivegna A, Redaelli S, Riva G, Butta V, Paoletta L, Isimbaldi G, Miozzo M, Tabano S, Daga A, Marubbi D, Cattaneo M, Biunno I, Dalprà L.

PLoS One. 2013;8(2):e57462. doi: 10.1371/journal.pone.0057462. Epub 2013 Feb 28.

15.

Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3.

Wan Y, Fei XF, Wang ZM, Jiang DY, Chen HC, Yang J, Shi L, Huang Q.

Chin J Cancer. 2012 Apr;31(4):207-14. doi: 10.5732/cjc.011.10336. Epub 2012 Feb 24.

16.

Rapamycin induces differentiation of glioma stem/progenitor cells by activating autophagy.

Zhuang WZ, Long LM, Ji WJ, Liang ZQ.

Chin J Cancer. 2011 Oct;30(10):712-20. doi: 10.5732/cjc.011.10234.

17.

Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells.

Filippi-Chiela EC, Villodre ES, Zamin LL, Lenz G.

PLoS One. 2011;6(6):e20849. doi: 10.1371/journal.pone.0020849. Epub 2011 Jun 13.

18.
19.

Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar.

Fei XF, Zhang QB, Dong J, Diao Y, Wang ZM, Li RJ, Wu ZC, Wang AD, Lan Q, Zhang SM, Huang Q.

J Exp Clin Cancer Res. 2010 Jun 29;29:84. doi: 10.1186/1756-9966-29-84.

20.

Supplemental Content

Support Center